Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice (Q84664163)
Jump to navigation
Jump to search
scientific article published on 04 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice |
scientific article published on 04 August 2010 |
Statements
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice (English)
Nicole M Agostino
Vernon M Chinchilli
Anita Koszyk-Szewczyk
Rebecca Gingrich
Jeffrey Sivik
Joseph J Drabick
4 August 2010